Progress on the correlation between exosomal microRNAs and Alzheimer's disease

Abstract

Abstract: Alzheimer's disease is the most common dementia in the aged population and is characterizd by hidden attack and progressive development. Some studies showed that exosomal microRNAs(miRNAs) regulates the shearing of amyloid precusor protein,deposition of beta-amyloid peptides(Aβ) and phosphorylation of Tau protein, influencing the generation of neuritic plaques and neurofibrillary tangles. In addition, special miRNAs can be transpor-ted by exsome across blood-brain-barrier and inhibit Tau phosphorylation. Measuring the expression profile of exosomal miRNAs in the peripheral blood may be a non-invasive diagnosis and treatment method of AD.

Key words: Alzheimer's disease, exosome, microRNAs, beta-amyloid peptide, Tau protein

CLC Number:

R592

DIAO Hua-qiong, LI Xiao-li, LIN Liang-yin, LIU Hai-peng, CHEN Hong-jing, DING Hai-yue, WEI Dan. Progress on the correlation between exosomal microRNAs and Alzheimer's disease[J]. Basic & Clinical Medicine, 2020, 40(11): 1542-1545.

References

[1] 饶明俐.阿尔茨海默病//吴江,贾建平.神经病学[M].北京:人民卫生出版,2015:364-365.
[2] Patterson C. World Alzheimer report 2018: the State of the art of dementia research: new frontiers[R]. Alzheimer's disease international (ADI): London,UK.2018.Accessed at https://www.alz.co.uk/news/world-alzheimer-report-2018-state-of-art-of-dementia-research-new-frontiers.
[3] Jia J, Wei C, Chen S,et al. The cost of Alzheimer's disease in China and re-estimation of costs worldwide[J]. Alzheimers Dement,2018,14: 483-491.
[4] 王涛.基于阿尔茨海默病病理假说的新药研发现状及展望(英文)[J].上海精神医学,2017,29:237-239.
[5] Zhou Q, Luo L, Wang XH,et al. Relationship between single nucleotide polymorphisms in the 3′UTR of amyloid precursor protein and risk of Alzheimer's disease and its mechanism[J]. Biosci Rep,2019.39: doi:10.1042/BSR20182485.
[6] Rajendran L, Honsho M,Zahn TR,et al.Alzheimer's disease β-amyloid peptides are released in association with exosomes[J]. Proc Natl Acad Sci,2006,103:11172-11177.
[7] Manzano-Crespo M, Atienza M, Cantero J. Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1-40 and cerebral vulnerability in normal aging[J].Transl Neurodegener,2019,8:doi:10. 1186/s40035-019-0174-8.
[8] Wang X, Tan L, Lu Y,et al. MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha[J]. FEBS Lett,2015,589:726-729.
[9] Maoz R, Garfinkel BP, Soreq H. Alzheimer's disease and ncRNAs[J].Adv Exp Med Bio,2017,978:337-361.
[10] Kumar S,Reddy PH. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?[J]. Biochim Biophys Acta,2016,1862:1617-1627.
[11] Zhang Z, Tang C, Zhao L,et al. Aptamer-based fluorescence polarization assay for separation-free exosome quantification[J]. Nanoscale,2019,11:10106-10113.
[12] Park JS, Kim ST, Kim SYA,et al. A novel kit for early diagnosis of Alzheimer's disease using a fluorescent nanoparticle imaging[J].Sci Rep,2019,9:doi:10.1038/s41598-019-49711-y.
[13] 赵娟娟,岳东旭,褚风云,等.微小RNAs在阿尔茨海默病Aβ沉积和Tau磷酸化中的作用[J].生命科学,2017,29:507-513.
[14] Patel AA, Ganepola GAP, et al.The potential role of dysregulated miRNAs in Alzheimer's disease pathogenesis and progression[J]. Alzheimers Dis,2019, 67:1123-1145.
[15] Jia L, Qiu Q, Zhang H,et al. Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral bloodneuronal-derived exosomes and cerebrospinal fluid[J].Alzheimers Dement,2019,15:1071-1080.
[16] Riancho J, Vázquez-HigueraJ, Pozueta A,et al. Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease[J]. J Alzheimers Dis,2017,57:483-491.
[17] Zhang Y, Xing H, Guo S,et al. MicroRNA-135b has a neuroprotective role via targeting of β-site APP-cleaving enzyme 1[J]. Exp Ther Med,2016,12:809-814.
[18] 刘辰庚,杨婷婷,王培昌.血清外泌体miRNA-193b诊断阿尔茨海默病的价值[J].实用医学杂志,2018,34:3621-3624.
[19] Ji Q, Wang X, Cai J,et al. miR-22-3p regulates amyloid β deposit in mice model of Alzheimer's disease by target-ing mitogen-activated protein kinase 14[J]. Curr Neurovasc Res,2019,18:285-291.
[20] Kim J, Yoon H, Chung D,et al. miR-186 is decreased in aged brain and suppresses BACE1 expression[J]. Neurochem,2016,137:436-445.
[21] Kang Q, Xiang Y, Li D,et al. miR-124-3p attenuates hyperphosphorylation of tau proteininduced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells[J]. Oncotarget,2017,8:24314-24326.
[22] Mai H, Fan W, Wang Y.Intranasal administration of miR-146a agomir rescued the pathological process and cognitive impairment in an AD mouse model[J].Mol Ther Nucleic Acids,2019,18:681-695.
[23] He D, Tan J, Zhang J. miR-137 attenuates Abeta-induced neurotoxicity through inactivation of NF-kappaB pathway by targeting TNFAIP1 in Neuro2a cells[J]. Biochem Biophys Res Commun,2017,490:941-947.
[24] Zhao Y, Zhao R, Wu J,et al. Melatonin protects against Abeta-induced neurotoxicity in primary neurons via miR-132/PTEN/AKT/FOXO3a pathway[J]. Biofactors,2018,44:609-618.
[25] Wang H, Sui H, Zheng Y,et al. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice byinhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3pathway[J]. Nanoscale,2019,11:7481-7496.
[26] Yang Y, Ye Y, Kong C,et al. miR-124 enriched exosomes promoted the M2 polarization of microglia and enhanced hippocampus neurogenesis after traumatic brain injury by inhibiting TLR4 pathway[J]. Neuroche Res,2019,44:811-828.